TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2010

Rituximab administration within 6 months of T cell-depleted allogeneic SCT is associated with prolonged life-threatening cytopenias.

Zachariah McIver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.